Paroxetine Hydrochloride Hemihydrate + Triazolam Interaction
Unknowninteraction on record
Description
In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfenadine, astemizole, cisapride, triazolam, and cyclosporine.
Source: FDA drug label - paroxetine hydrochloride hemihydrate